DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: OCREVUS (ocrelizumab)
       *****************************************************
       #Post#: 2077--------------------------------------------------
       (McGill University) Developing the first effective drug for PPMS
       By: agate Date: May 11, 2018, 1:24 pm
       ---------------------------------------------------------
       An informative news story about Ocrevus from McGill University
       in Canada (May 11, 2018), "Developing the first effective drug
       for progressive MS":
  HTML http://publications.mcgill.ca/medenews/2018/05/10/developing-the-first-effective-drug-for-progressive-ms/
       This part is something I haven't seen mentioned much elsewhere:
       [quote]
       [font=arial]It should be noted that clinical data came from
       patients between the ages of 18 and 55.[/font]
       [font=arial]“It’s not clear how well ocrelizumab works in older
       people who have had progressive multiple sclerosis for a long
       time,” cautions Dr. Arnold [a neurologist who worked in the
       development of ocrelizumab], adding that research
       continues.[/font]
       [font=arial]The Multiple Sclerosis Society of Canada notes that
       “the safety and efficacy of ocrelizumab outside of the age range
       of 18 to 55 is unknown.” The Society advises older patients who
       are interested in ocrelizumab to consult their
       neurologist.[/font]
       [/quote]
       *****************************************************